0000000000454686

AUTHOR

Elisa Villa

showing 4 related works from this author

Fusulines of the Hoyo Oscuro section, Ándara massif of Picos de Europa (Cantabrian Zone, N Spain). New constraints about the onset of the Variscan de…

2020

The Hoyo Oscuro section (Andara Massif, southeastern part of Picos de Europa) is a comparatively small exposure of Pennsylvanian syntectonic deposits that shown angular unconformity on the fairly extensive pre-tectonic carbonate platform strata of Pennsylvanian age accumulated in the distalmost realms of the Variscan foreland basin of the Cantabrian Zone. Fusuline-bearing strata from this section yielded species belonging to the genera P seudostaffella, Ozawainella, Fusulinella, Protriticites, Pseudotriticites, Fusulina and Quasifusulinoides ; one of these forms, Protriticites schulzei Villa, is described as a new species from the Cantabrian Mountains. Fusuline assemblages allow us to corre…

geographygeography.geographical_feature_categoryAnchor pointCarbonate platformPaleontologyOrogenyMassifQE701-760UnconformityPaleontologySection (archaeology)PennsylvanianForeland basinGeologyfusulines carboniferous (pennsylvanian) cantabrian zone variscan orogeny picos de europa
researchProduct

Severe asthma and COVID-19: lessons from the first wave

2020

Objective: Severe asthma is considered a risk factor for SARS-Coronavirus 2 (SARS-CoV-2) infection but scientific evidences are lacking. Methods: we performed a literature search and review based on PubMed database national, international recommendations as well as papers on severe asthmatic patients and their management during SARS-CoV-2 pandemic. Results: the majority of international recommendations, expert panels and editorials provide indications about management of severe asthmatic patients. No published studies evaluated the effects of biologic agents on severe asthmatic patients during SARS-CoV-2 pandemic. Conclusions: the relationship between SARS-CoV-2 and asthma is variable world…

Pulmonary and Respiratory Medicinesevere asthma2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)biologic agentsvirusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe asthmaInhaled corticosteroidsSettore MED/10 - Malattie Dell'Apparato Respiratoriooral corticosteroids03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansImmunology and AllergyAnti-Asthmatic AgentsPediatrics Perinatology and Child Health030212 general & internal medicineRisk factorskin and connective tissue diseasesPandemicsAsthmabusiness.industryAsthma; biologic agents; COVID-19; inhaled corticosteroids; oral corticosteroids; SARS-CoV-2; severe asthmaSARS-CoV-2fungiPatient AcuityAsthma biologic agents COVID-19 inhaled corticosteroids oral corticosteroids SARS-CoV-2 severe asthmaCOVID-19medicine.diseaseAsthmarespiratory tract diseasesBiologic Agentsbody regions030228 respiratory systemPractice Guidelines as TopicPediatrics Perinatology and Child Healthinhaled corticosteroidsbusiness
researchProduct

Una asociación peculiar de fusulinas en las calizas de Tanes, sección de Campo de Caso (Pensilvánico, Moscoviense superior; zona Cantábrica, España)

2021

The Campo de Caso section (eastern part of the Cantabrian Zone, NW Spain) exposes a middle to upper Moscovian (Middle Pennsylvanian) succession, up to 3500-m thick, consisting of marine shelfal and deltaic siliciclastic and shale deposits with numerous intercalated fossiliferous limestones. A limestone outcropping in the upper part of this section, close to the village of Tanes, has yielded a fusuline assemblage composed of species of the genera  Eostaffella, Pseudonovella, Ozawainella, Pseudostaffella, Neostaffella, Schubertella, Fusiella, Taitzehoella, Fusulinella, Beedeina and  Putrella . The specific composition of these genera, considered as a whole, indicates an early to mid- Myachkov…

PaleontologyTaxonOutcropSection (archaeology)PennsylvanianPaleontologyAssemblage (archaeology)SiliciclasticEcological successionGeology
researchProduct

Severe asthma at COVID-19 time: what is new on biologic therapies.

2021

medicine.medical_specialty2019-20 coronavirus outbreakAsthma therapyCoronavirus disease 2019 (COVID-19)business.industrySevere asthmaBiologic therapiesMEDLINECOVID-19General MedicineSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaseSeverity of Illness IndexAsthmaAsthma; COVID-19; Humans; Severity of Illness Index; Biological TherapyBiological TherapyInternal medicineSeverity of illnessmedicineHumansbusinessAsthmaHumanMinerva medica
researchProduct